{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["advanced glycation end-products", "aldose reductase", "diabetic retinopathy", "metalloproteinase-9", "mitogen-activated protein kinases", "oxidative stress", "phytochemicals", "poly (ADP-ribose) polymerase", "protein kinase C", "reactive oxygen species", "vascular endothelial growth factor"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29937497", "DateCompleted": {"Year": "2018", "Month": "10", "Day": "10"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["1519", "10.3390/molecules23071519"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "23", "Issue": "7", "PubDate": {"Year": "2018", "Month": "Jun", "Day": "23"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy.", "Abstract": {"AbstractText": ["<i>Background</i>: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patient\u2019s condition. Medicinal plants and their derived phytochemicals are considered safe and effective treatment and their consumption can reduce the DR risk. In this article, we discuss a variety of medicinal plants, and their noteworthy bio-active constituents, that will be utilized as target based therapeutic strategies for DR. <i>Methods</i>: A broad-spectrum study was conducted using published English works in various electronic databases including Science Direct, PubMed, Scopus, and Google Scholar. <i>Results</i>: Targeting the multiple pathological factors including ROS, AGEs formation, hexosamine flux, PARP, PKC, and MAPK activation through variety of bioactive constituents in medicinal plants, diabetes progression can be delayed with improved loss of vision. <i>Conclusions</i>: Data reveals that traditional herbs and their prominent bioactive components control and normalize pathological cellular factors involved in DR progression. Therefore, studies should be carried out to explore the protective retinopathy effects of medicinal plants using experimental animal and humans models."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Government College University Faisalabad, Faisalabad 3800, Pakistan. amnaparvin@gmail.com."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. amnaparvin@gmail.com."}], "LastName": "Parveen", "ForeName": "Amna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. nirvana995@naver.com."}], "LastName": "Kim", "ForeName": "Jin Hyun", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. saxa12@naver.com."}], "LastName": "Oh", "ForeName": "Byeong Gyu", "Initials": "BG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. subedilali@gmail.com."}], "LastName": "Subedi", "ForeName": "Lalita", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. Zahra.khan37@gmail.com."}], "LastName": "Khan", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": ["0000-0001-8044-5613"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University, Hambakmoero, Yeonsu-gu, Incheon 406-799, Korea. sunnykim@gachon.ac.kr."}, {"Identifier": [], "Affiliation": "Gachon Institute of Pharmaceutical Science, Gachon University, Hambakmoe-ro, Yeonsu-gu, Incheon 406-799, Korea. sunnykim@gachon.ac.kr."}], "LastName": "Kim", "ForeName": "Sun Yeou", "Initials": "SY"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycation End Products, Advanced"}, {"RegistryNumber": "0", "NameOfSubstance": "Hexosamines"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "EC 2.4.2.30", "NameOfSubstance": "Poly(ADP-ribose) Polymerases"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C"}, {"RegistryNumber": "EC 2.7.11.24", "NameOfSubstance": "Mitogen-Activated Protein Kinases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Diabetic Retinopathy"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Glycation End Products, Advanced"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Hexosamines"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Mitogen-Activated Protein Kinases"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Poly(ADP-ribose) Polymerases"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Protein Kinase C"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Retina"}], "CoiStatement": "There is no conflict of interest among authors."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Roglic G. WHO Global report on diabetes: A summary. Int. J. Noncommun. Dis. 2016;1:3\u20138. doi: 10.4103/2468-8827.184853.", "ArticleIdList": ["10.4103/2468-8827.184853"]}, {"Citation": "Ting D.S.W., Cheung G.C.M., Wong T.Y. Diabetic retinopathy: Global prevalence, major risk factors, screening practices and public health challenges: A review. Clin. Exp. Ophthalmol. 2016;44:260\u2013277. doi: 10.1111/ceo.12696.", "ArticleIdList": ["10.1111/ceo.12696", "26716602"]}, {"Citation": "Feenstra D.J., Yego E.C., Mohr S. Modes of retinal cell death in diabetic retinopathy. J. Clin. Exp. Ophthalmol. 2013;4:298.", "ArticleIdList": ["PMC3963519", "24672740"]}, {"Citation": "Calderon G.D., Juarez O.H., Hernandez G.E., Punzo S.M., De la Cruz Z.D. Oxidative stress and diabetic retinopathy: Development and treatment. Eye. 2017;31:1122\u20131130. doi: 10.1038/eye.2017.64.", "ArticleIdList": ["10.1038/eye.2017.64", "PMC5558229", "28452994"]}, {"Citation": "Safi S.Z., Qvist R., Kumar S., Batumalaie K., Ismail I.S.B. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. BioMed res. Int. 2014;2014:801269. doi: 10.1155/2014/801269.", "ArticleIdList": ["10.1155/2014/801269", "PMC4106080", "25105142"]}, {"Citation": "Li C., Miao X., Li F., Wang S., Liu Q., Wang Y., Sun J. Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy. Oxidative Med. Cell. Longev. 2017;2017:9702820. doi: 10.1155/2017/9702820.", "ArticleIdList": ["10.1155/2017/9702820", "PMC5317113", "28265339"]}, {"Citation": "Efferth T., Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets. 2011;12:122\u2013132. doi: 10.2174/138945011793591626.", "ArticleIdList": ["10.2174/138945011793591626", "20735354"]}, {"Citation": "Dal S., Sigrist S. The protective effect of antioxidants consumption on diabetes and vascular complications. Diseases. 2016;4:24. doi: 10.3390/diseases4030024.", "ArticleIdList": ["10.3390/diseases4030024", "PMC5456287", "28933404"]}, {"Citation": "Parveen A., Jin M., Kim S.Y. Bioactive phytochemicals that regulate the cellular processes involved in Diabetic nephropathy. Phytomedicine. 2018;39:146\u2013159. doi: 10.1016/j.phymed.2017.12.018.", "ArticleIdList": ["10.1016/j.phymed.2017.12.018", "29433676"]}, {"Citation": "Jeetah R., Bhaw-Luximon A., Jhurry D. Nanopharmaceutics: Phytochemical-based controlled or sustained drug-delivery systems for cancer treatment. J. Biomed. Nanotechnol. 2014;10:1810\u20131840. doi: 10.1166/jbn.2014.1884.", "ArticleIdList": ["10.1166/jbn.2014.1884", "25992442"]}, {"Citation": "Dewan N., Dasgupta D., Pandit S., Ahmed P. Review on-Herbosomes, A new arena for drug delivery. J. Pharmacogn. Phytochem. 2016;5:104."}, {"Citation": "Mishra B., Swaroop A., Kandpal R.P. Genetic components in diabetic retinopathy. Indian J. Ophthalmol. 2016;64:55\u201361.", "ArticleIdList": ["PMC4821123", "26953025"]}, {"Citation": "Chuang P.Y., He J.C. JAK/STAT signaling in renal diseases. Kidney Int. 2010;78:231\u2013234. doi: 10.1038/ki.2010.158.", "ArticleIdList": ["10.1038/ki.2010.158", "20631733"]}, {"Citation": "Marrero M.B., Banes-Berceli A.K., Stern D.M., Eaton D.C. Role of the JAK/STAT signaling pathway in diabetic nephropathy. Am. J. Physiol.-Renal Physiol. 2006;290:F762\u2013F768. doi: 10.1152/ajprenal.00181.2005.", "ArticleIdList": ["10.1152/ajprenal.00181.2005", "16527921"]}, {"Citation": "Zong H., Ward M., Stitt A.W. AGEs, RAGE, and diabetic retinopathy. Curr. Diabetes Rep. 2011;11:244\u2013252. doi: 10.1007/s11892-011-0198-7.", "ArticleIdList": ["10.1007/s11892-011-0198-7", "21590515"]}, {"Citation": "Geraldes P., King G.L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 2010;106:1319\u20131331. doi: 10.1161/CIRCRESAHA.110.217117.", "ArticleIdList": ["10.1161/CIRCRESAHA.110.217117", "PMC2877591", "20431074"]}, {"Citation": "Koya D., Haneda M., Nakagawa H., Isshiki K., Sato H., Maeda S., Sugimoto T., Yasuda H., Kashiwagi A., Ways D.K. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC \u03b2 inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 2000;14:439\u2013447. doi: 10.1096/fasebj.14.3.439.", "ArticleIdList": ["10.1096/fasebj.14.3.439", "10698958"]}, {"Citation": "Goldberg H.J., Whiteside C.I., Fantus I.G. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-\u03b2I and-\u03b4. J. Biol. Chem. 2002;277:33833\u201333841. doi: 10.1074/jbc.M112331200.", "ArticleIdList": ["10.1074/jbc.M112331200", "12105191"]}, {"Citation": "Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: Attractive, elusive, and resilient. J. Diabetes Res. 2007;2007:61038. doi: 10.1155/2007/61038.", "ArticleIdList": ["10.1155/2007/61038", "PMC1950230", "18224243"]}, {"Citation": "Mathebula S.D. Polyol pathway: A possible mechanism of diabetes complications in the eye. Afr. Vis. Eye Health. 2015;74 doi: 10.4102/aveh.v74i1.13.", "ArticleIdList": ["10.4102/aveh.v74i1.13"]}, {"Citation": "Luo D.-W., Zheng Z., Wang H., Fan Y., Chen F., Sun Y., Wang W.-J., Sun T., Xu X. UPP mediated Diabetic Retinopathy via ROS/PARP and NF-\u03baB inflammatory factor pathways. Curr. Mol. Med. 2015;15:790\u2013799. doi: 10.2174/1566524015666150921110500.", "ArticleIdList": ["10.2174/1566524015666150921110500", "26391545"]}, {"Citation": "Mishra M., Kowluru R.A. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2017;1863:1761\u20131769. doi: 10.1016/j.bbadis.2017.04.024.", "ArticleIdList": ["10.1016/j.bbadis.2017.04.024", "PMC5599300", "28478229"]}, {"Citation": "Li H.M., Kim J.K., Jang J.M., Cui C.B., Lim S.S. Analysis of the inhibitory activity of Abeliophyllum distichum leaf constituents against aldose reductase by using high-speed counter current chromatography. Arch. Pharm. Res. 2013;36:1104\u20131112. doi: 10.1007/s12272-013-0127-1.", "ArticleIdList": ["10.1007/s12272-013-0127-1", "23645536"]}, {"Citation": "Sankeshi V., Kumar P.A., Naik R.R., Sridhar G., Kumar M.P., Gopal V.V., Raju T.N. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract. J. Ethnopharmacol. 2013;149:215\u2013221. doi: 10.1016/j.jep.2013.06.025.", "ArticleIdList": ["10.1016/j.jep.2013.06.025", "23827758"]}, {"Citation": "Kim S.B., Hwang S.H., Suh H.W., Lim S.S. Phytochemical Analysis of Agrimonia pilosa Ledeb, Its Antioxidant Activity and Aldose Reductase Inhibitory Potential. Int. J. Mol. Sci. 2017;18:379. doi: 10.3390/ijms18020379.", "ArticleIdList": ["10.3390/ijms18020379", "PMC5343914", "28208627"]}, {"Citation": "Guo T., Zhu L., Tan J., Zhou X., Xiao L., Liu X., Wang B. Promoting effect of triterpenoid compound from Agrimonia pilosa Ledeb on preadipocytes differentiation via up-regulation of PPAR\u03b3 expression. Pharmacogn. Mag. 2015;11:219\u2013225.", "ArticleIdList": ["PMC4329626", "25709235"]}, {"Citation": "Kim J., Jo K., Lee I.-S., Kim C.-S., Kim J.S. The extract of aster koraiensis prevents retinal pericyte apoptosis in diabetic rats and its active compound, chlorogenic acid inhibits AGE formation and AGE/RAGE interaction. Nutrients. 2016;8:585. doi: 10.3390/nu8090585.", "ArticleIdList": ["10.3390/nu8090585", "PMC5037569", "27657123"]}, {"Citation": "Kim Y.S., Kim J., Kim K.M., Jung D.H., Choi S., Kim C.-S., Kim J.S. Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo. Biochem. Pharmacol. 2015;93:496\u2013505. doi: 10.1016/j.bcp.2014.09.022.", "ArticleIdList": ["10.1016/j.bcp.2014.09.022", "25450667"]}, {"Citation": "Hafsa J., Hammi K.M., Khedher M.R.B., Smach M.A., Charfeddine B., Limem K., Majdoub H. Inhibition of protein glycation, antioxidant and antiproliferative activities of Carpobrotus edulis extracts. Biomed. Pharmacother. 2016;84:1496\u20131503. doi: 10.1016/j.biopha.2016.11.046.", "ArticleIdList": ["10.1016/j.biopha.2016.11.046", "27876336"]}, {"Citation": "Raghu G., Akileshwari C., Reddy V.S., Reddy G.B. Attenuation of diabetic retinopathy in rats by ellagic acid through inhibition of AGE formation. J. Food Sci. Technol. 2017;54:2411\u20132421. doi: 10.1007/s13197-017-2683-8.", "ArticleIdList": ["10.1007/s13197-017-2683-8", "PMC5502036", "28740299"]}, {"Citation": "Stefek M. Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip. Toxicol. 2011;4:69\u201377. doi: 10.2478/v10102-011-0013-y.", "ArticleIdList": ["10.2478/v10102-011-0013-y", "PMC3131677", "21753902"]}, {"Citation": "Devi V.G., Rooban B.N., Sasikala V., Sahasranamam V., Abraham A. Isorhamnetin-3-glucoside alleviates oxidative stress and opacification in selenite cataract in vitro. Toxicol In Vitro. 2010;24:1662\u20131669. doi: 10.1016/j.tiv.2010.05.021.", "ArticleIdList": ["10.1016/j.tiv.2010.05.021", "20566334"]}, {"Citation": "Lee Y.M., Kim J., Kim C.-S., Jo K., Yoo N.H., Sohn E., Kim J.S. Anti-glycation and anti-angiogenic activities of 5\u2032-methoxybiphenyl-3,4,3\u2032-triol, a novel phytochemical component of Osteomeles schwerinae. Eur. J. Pharmacol. 2015;760:172\u2013178. doi: 10.1016/j.ejphar.2015.04.022.", "ArticleIdList": ["10.1016/j.ejphar.2015.04.022", "25917323"]}, {"Citation": "Gong C.-Y., Yu Z.-Y., Lu B., Yang L., Sheng Y.-C., Fan Y.-M., Ji L.-L., Wang Z.-T. Ethanol extract of Dendrobium chrysotoxum Lindl ameliorates diabetic retinopathy and its mechanism. Vasc. Pharmacol. 2014;62:134\u2013142. doi: 10.1016/j.vph.2014.04.007.", "ArticleIdList": ["10.1016/j.vph.2014.04.007", "24846859"]}, {"Citation": "Yu Z., Gong C., Lu B., Yang L., Sheng Y., Ji L., Wang Z. Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease. J. Diabetes Res. 2015;2015:518317. doi: 10.1155/2015/518317.", "ArticleIdList": ["10.1155/2015/518317", "PMC4313057", "25685822"]}, {"Citation": "Chen C.O., Chen D., Fang H., Wu J., Wei X., Gao X., Li X., Long Y., Yi Y. Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract. BMC Complement. Altern. Med. 2016;16:286.", "ArticleIdList": ["PMC4983052", "27520089"]}, {"Citation": "Bucolo C., Marrazzo G., Platania C.B.M., Drago F., Leggio G.M., Salomone S. Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy. J. Diabetes Res. 2013;2013:432695. doi: 10.1155/2013/432695.", "ArticleIdList": ["10.1155/2013/432695", "PMC3676923", "23762874"]}, {"Citation": "Huang S.-Y., Jeng C., Kao S.-C., Yu J.J.-H., Liu D.-Z. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin. Nutr. 2004;23:615\u2013621. doi: 10.1016/j.clnu.2003.10.010.", "ArticleIdList": ["10.1016/j.clnu.2003.10.010", "15297098"]}, {"Citation": "Spadiene A., Savickiene N., Jurgeviciene N., Zalinkevicius R., Norkus A., Ostrauskas R., Skesters A., Silova A., Rodovicius H., Francaite-Daugeliene M. Effect of ginkgo extract on eye microcirculation in patients with diabetes. Cent. Eur. J. Med. 2013;8:736\u2013741. doi: 10.2478/s11536-012-0146-1.", "ArticleIdList": ["10.2478/s11536-012-0146-1"]}, {"Citation": "Zhu C.-Y., Yi Q., Ma J.-L., Wei Q.-P. Clinical evaluation of Ginkgo biloba extract for diabetic retinopathy. Guoji Yanke Zazhi. 2016;16:361\u2013364."}, {"Citation": "Lee Y.S., Kim S.H., Jung S.H., Kim J.K., Pan C.-H., Lim S.S. Aldose reductase inhibitory compounds from Glycyrrhiza uralensis. Biol. Pharm. Bull. 2010;33:917\u2013921. doi: 10.1248/bpb.33.917.", "ArticleIdList": ["10.1248/bpb.33.917", "20460778"]}, {"Citation": "Nasiry D., Khalatbary A.R., Ahmadvand H. Therapeutic potential of Juglans regia L. leaf extract against diabetic retinopathy in rat. Iran. J. Basic Med. Sci. 2017;20:1275\u20131281.", "ArticleIdList": ["PMC5749363", "29299206"]}, {"Citation": "Kilari E.K., Putta S. Delayed progression of diabetic cataractogenesis and retinopathy by Litchi chinensis in STZ-induced diabetic rats. Cutan. Ocul. Toxicol. 2017;36:52\u201359. doi: 10.3109/15569527.2016.1144610.", "ArticleIdList": ["10.3109/15569527.2016.1144610", "27160797"]}, {"Citation": "Wu J., Ke X., Fu W., Gao X., Zhang H., Wang W., Ma N., Zhao M., Hao X., Zhang Z. Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1\u03b1/VEGF Signaling Pathway. Molecules. 2016;21:1756. doi: 10.3390/molecules21121756.", "ArticleIdList": ["10.3390/molecules21121756", "PMC6272965", "28009852"]}, {"Citation": "Zhou L., Zhang T., Lu B., Yu Z., Mei X., Abulizi P., Ji L. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. J. Ethnopharmacol. 2016;189:117\u2013125. doi: 10.1016/j.jep.2016.05.039.", "ArticleIdList": ["10.1016/j.jep.2016.05.039", "27196298"]}, {"Citation": "Shin J.Y., Sohn J., Park K.H. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model. J. Korean Med. Sci. 2013;28:608\u2013613. doi: 10.3346/jkms.2013.28.4.608.", "ArticleIdList": ["10.3346/jkms.2013.28.4.608", "PMC3617316", "23579598"]}, {"Citation": "Mei X., Zhou L., Zhang T., Lu B., Sheng Y., Ji L. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Vasc. Pharmacol. 2017;101:29\u201337. doi: 10.1016/j.vph.2017.11.002.", "ArticleIdList": ["10.1016/j.vph.2017.11.002", "29146180"]}, {"Citation": "Khodsooz S., Moshtaghian J., Eivani M. Antihyperglycemic and antihyperlipidemic effects of hydroalcoholic extract of Melissa officinalis (Lemon Balm) in alloxan-induced diabetic rats. Physiol. Pharmacol. 2016;20:24\u201330."}, {"Citation": "Miroliaei M., Khazaei S., Moshkelgosha S., Shirvani M. Inhibitory effects of Lemon balm (Melissa officinalis, L.) extract on the formation of advanced glycation end products. Food Chem. 2011;129:267\u2013271. doi: 10.1016/j.foodchem.2011.04.039.", "ArticleIdList": ["10.1016/j.foodchem.2011.04.039", "30634225"]}, {"Citation": "Kim J.H., Lee B.J., Kim J.H., Yu Y.S., Kim M.Y., Kim K.-W. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21 WAF1 expression. Eur. J. Pharmacol. 2009;615:150\u2013154. doi: 10.1016/j.ejphar.2009.05.015.", "ArticleIdList": ["10.1016/j.ejphar.2009.05.015", "19470386"]}, {"Citation": "Kumar Gupta S., Kumar B., Srinivasan B., Nag T.C., Srivastava S., Saxena R., Aggarwal A. Retinoprotective effects of Moringa oleifera via antioxidant, anti-inflammatory, and anti-angiogenic mechanisms in streptozotocin-induced diabetic rats. J. Ocul. Pharmacol. Ther. 2013;29:419\u2013426. doi: 10.1089/jop.2012.0089.", "ArticleIdList": ["10.1089/jop.2012.0089", "23215831"]}, {"Citation": "Ke M., Hu X.-Q., Ouyang J., Dai B., Xu Y. The effect of astragalin on the VEGF production of cultured M\u00fcller cells under high glucose conditions. Bio-med. Mater. Eng. 2012;22:113\u2013119.", "ArticleIdList": ["22766709"]}, {"Citation": "Mahmoud A.M., El-Twab S.M.A., Abdel-Reheim E.S. Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: The underlying mechanism. Eur. J. Nutr. 2017;56:1671\u20131684. doi: 10.1007/s00394-016-1214-0.", "ArticleIdList": ["10.1007/s00394-016-1214-0", "27059477"]}, {"Citation": "Paek J.H., Shin K.H., Kang Y.H., Lee J.Y., Lim S.S. Rapid identification of aldose reductase inhibitory compounds from Perilla frutescens. Biomed. Res. Int. 2013;2013:679463. doi: 10.1155/2013/679463.", "ArticleIdList": ["10.1155/2013/679463", "PMC3838804", "24308003"]}, {"Citation": "Jang D.S., Lee Y.M., Jeong I.H., Kim J.S. Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advanced glycation end products and rat lens aldose reductase in vitro. Arch. Pharm. Res. 2010;33:875\u2013880. doi: 10.1007/s12272-010-0610-x.", "ArticleIdList": ["10.1007/s12272-010-0610-x", "20607492"]}, {"Citation": "Ojha S., Balaji V., Sadek B., Rajesh M. Beneficial effects of phytochemicals in diabetic retinopathy: Experimental and clinical evidence. Eur. Rev. Med. Pharmacol. Sci. 2017;21:2769\u20132783.", "ArticleIdList": ["28678306"]}, {"Citation": "Dong W., Shi H.B., Ma H., Miao Y.B., Liu T.J., Wang W. Homoisoflavanones from Polygonatum odoratum rhizomes inhibit advanced glycation end product formation. Arch. Pharm. Res. 2010;33:669\u2013674. doi: 10.1007/s12272-010-0504-y.", "ArticleIdList": ["10.1007/s12272-010-0504-y", "20512463"]}, {"Citation": "Sohn E., Kim J., Kim C.-S., Lee Y.M., Kim J.S. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats. Nutrients. 2016;8:140. doi: 10.3390/nu8030140.", "ArticleIdList": ["10.3390/nu8030140", "PMC4808869", "26950148"]}, {"Citation": "Xue L., Wu K., Qiu H., Huang B., Chen R., Xie W., Jiang Q. Polydatin exhibits the hepatoprotective effects through PPAR-\u03b1/-\u03b2 signaling pathway in Streptozocin-induced diabetic mice. J. Funct. Foods. 2017;36:341\u2013347. doi: 10.1016/j.jff.2017.07.015.", "ArticleIdList": ["10.1016/j.jff.2017.07.015"]}, {"Citation": "Lv L., Shao X., Wang L., Huang D., Ho C.-T., Sang S. Stilbene glucoside from Polygonum multiflorum Thunb.: A novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal. J. Agric. Food Chem. 2010;58:2239\u20132245. doi: 10.1021/jf904122q.", "ArticleIdList": ["10.1021/jf904122q", "20104848"]}, {"Citation": "Li H.M., Kim J.K., Jang J.M., Kwon S.O., Cui C.B., Lim S.S. The inhibitory effect of Prunella vulgaris L. on aldose reductase and protein glycation. BioMed Res. Int. 2012;2012:928159.", "ArticleIdList": ["PMC3471066", "23091363"]}, {"Citation": "Behl T., Kotwani A. Chinese herbal drugs for the treatment of diabetic retinopathy. J. Pharm. Pharmacol. 2017;69:223\u2013235. doi: 10.1111/jphp.12683.", "ArticleIdList": ["10.1111/jphp.12683", "28124440"]}, {"Citation": "Teng Y., Cui H., Yang M., Song H., Zhang Q., Su Y., Zheng J. Protective effect of puerarin on diabetic retinopathy in rats. Mol. Biol. Rep. 2009;36:1129. doi: 10.1007/s11033-008-9288-2.", "ArticleIdList": ["10.1007/s11033-008-9288-2", "18587665"]}, {"Citation": "Kim J., Kim K.M., Kim C.S., Sohn E., Lee Y.M., Jo K., Kim J.S. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic. Biol. Med. 2012;53:357\u2013365. doi: 10.1016/j.freeradbiomed.2012.04.030.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.04.030", "22609359"]}, {"Citation": "Zhang L., Dai S.-Z., Nie X.-D., Zhu L., Xing F., Wang L.-Y. Effect of Salvia miltiorrhiza on retinopathy. Asian Pac. J. Trop. Med. 2013;6:145\u2013149. doi: 10.1016/S1995-7645(13)60011-5.", "ArticleIdList": ["10.1016/S1995-7645(13)60011-5", "23339918"]}, {"Citation": "Lian F., Wu L., Tian J., Jin M., Zhou S., Zhao M., Wei L., Zheng Y., Wang Y., Zhang M. The effectiveness and safety of a danshen-containing Chinese herbal medicine for diabetic retinopathy: A randomized, double-blind, placebo-controlled multicenter clinical trial. J. Ethnopharmacol. 2015;164:71\u201377. doi: 10.1016/j.jep.2015.01.048.", "ArticleIdList": ["10.1016/j.jep.2015.01.048", "25666427"]}, {"Citation": "Ma H.Y., Gao H.Y., Sun L., Huang J., Xu X.M., Wu L.J. Constituents with alpha-glucosidase and advanced glycation end-product formation inhibitory activities from Salvia miltiorrhiza Bge. J. Nat. Med. 2011;65:37\u201342. doi: 10.1007/s11418-010-0453-2.", "ArticleIdList": ["10.1007/s11418-010-0453-2", "20835851"]}, {"Citation": "Qiang G., Yang X., Shi L., Zhang H., Chen B., Zhao Y., Zu M., Zhou D., Guo J., Yang H. Antidiabetic effect of salvianolic acid A on diabetic animal models via AMPK activation and mitochondrial regulation. Cell. Physiol. Biochem. 2015;36:395\u2013408. doi: 10.1159/000430258.", "ArticleIdList": ["10.1159/000430258", "25967977"]}, {"Citation": "Hwang S.H., Kwon S.H., Kim S.B., Lim S.S. Inhibitory Activities of Stauntonia hexaphylla Leaf Constituents on Rat Lens Aldose Reductase and Formation of Advanced Glycation End Products and Antioxidant. BioMed Res. Int. 2017;2017:4273257. doi: 10.1155/2017/4273257.", "ArticleIdList": ["10.1155/2017/4273257", "PMC5343222", "28326319"]}, {"Citation": "Bhadada S.V., Vyas V.K., Goyal R.K. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity. Biomed. Pharmacother. 2016;83:221\u2013228. doi: 10.1016/j.biopha.2016.05.018.", "ArticleIdList": ["10.1016/j.biopha.2016.05.018", "27372406"]}, {"Citation": "Behl T., Kotwani A. Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications. J. Pharmacy Pharmacol. 2016 doi: 10.1111/jphp.12676.", "ArticleIdList": ["10.1111/jphp.12676", "28000229"]}, {"Citation": "Huang M., Zhang Y., Xu S., Xu W., Chu K., Xu W., Zhao H., Lu J. Identification and quantification of phenolic compounds in Vitex negundo L. var. cannabifolia (Siebold et Zucc.) Hand.-Mazz. using liquid chromatography combined with quadrupole time-of-flight and triple quadrupole mass spectrometers. J. Pharm. Biomed. Anal. 2015;108:11\u201320. doi: 10.1016/j.jpba.2015.01.049.", "ArticleIdList": ["10.1016/j.jpba.2015.01.049", "25703235"]}, {"Citation": "Thiraphatthanavong P., Wattanathorn J., Muchimapura S., Wipawee T.M., Wannanon P., Terdthai T.U., Suriharn B., Lertrat K. Preventive effect of Zea mays L. (purple waxy corn) on experimental diabetic cataract. Biomed. Res. Int. 2014;2014:507435. doi: 10.1155/2014/507435.", "ArticleIdList": ["10.1155/2014/507435", "PMC3914321", "24527449"]}, {"Citation": "Chompoo J., Upadhyay A., Kishimoto W., Makise T., Tawata S. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. Food Chem. 2011;129:709\u2013715. doi: 10.1016/j.foodchem.2011.04.034.", "ArticleIdList": ["10.1016/j.foodchem.2011.04.034", "25212289"]}, {"Citation": "Yu Z., Lu B., Sheng Y., Zhou L., Ji L., Wang Z. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation. Biochim. Biophys. Acta. 2015;1850:824\u2013831. doi: 10.1016/j.bbagen.2015.01.014.", "ArticleIdList": ["10.1016/j.bbagen.2015.01.014", "25641276"]}, {"Citation": "Ding Y., Yuan S., Liu X., Mao P., Zhao C., Huang Q., Zhang R., Fang Y., Song Q., Yuan D., et al. Protective effects of astragaloside IV on db/db mice with diabetic retinopathy. PLoS ONE. 2014;9:e112207. doi: 10.1371/journal.pone.0112207.", "ArticleIdList": ["10.1371/journal.pone.0112207", "PMC4239035", "25411784"]}, {"Citation": "Perez Gutierrez R.M. Inhibition of Advanced Glycation End-Product Formation by Origanum majorana L. In Vitro and in Streptozotocin-Induced Diabetic Rats. Evid. Based Complement. Altern. Med. 2012;2012:598638. doi: 10.1155/2012/598638.", "ArticleIdList": ["10.1155/2012/598638", "PMC3447365", "23008741"]}, {"Citation": "Wang Z.-H., Hsu C.-C., Huang C.-N., Yin M.-C. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur. J. Pharmacol. 2010;628:255\u2013260. doi: 10.1016/j.ejphar.2009.11.019.", "ArticleIdList": ["10.1016/j.ejphar.2009.11.019", "19917277"]}, {"Citation": "Sun Y., Sun X., Wang F., Liu S. Inhibitory effects of ursolic acid on diabetic retinopathy in mice. Zhonghua Yi Xue Za Zhi. 2015;95:2589\u20132593.", "ArticleIdList": ["26711605"]}, {"Citation": "Sen S., Chen S., Wu Y., Feng B., Lui E.K., Chakrabarti S. Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytother. Res. 2013;27:290\u2013298. doi: 10.1002/ptr.4719.", "ArticleIdList": ["10.1002/ptr.4719", "22566158"]}, {"Citation": "Godoy D.L., Betts-Obregon B.S., Tsin A.T. Ginsenoside-Rb1 inhibition of VEGF release\u2013structure and activity relations (sar) perspective. Med. Hypothesis Discov. Innov. Ophthalmol. 2014;3:38\u201339.", "ArticleIdList": ["PMC4346675", "25738157"]}, {"Citation": "Sun H.-Q., Zhou Z.-Y. Effect of ginsenoside-Rg3 on the expression of VEGF and TNF-\u03b1 in retina with diabetic rats. Int. J. Ophthalmol. 2010;3:220\u2013223.", "ArticleIdList": ["PMC3340625", "22553558"]}, {"Citation": "Liu W.Y., Tzeng T.F., Liu I.M. Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-kappaB Pathways. Molecules. 2016;21:1708. doi: 10.3390/molecules21121708.", "ArticleIdList": ["10.3390/molecules21121708", "PMC6273957", "27973425"]}, {"Citation": "Kim C.-S., Sohn E., Kim J.S., Kim J., Jo K., Lee Y.-R., Lee Y.M. Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivo. BMC Complement. Altern. Med. 2016;16:231.", "ArticleIdList": ["PMC4949763", "27435599"]}, {"Citation": "Song M., Salam N.K., Roufogalis B.D., Huang T.H.-W. Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-\u03b3-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment. Biochem. Pharmacol. 2011;82:1209\u20131218. doi: 10.1016/j.bcp.2011.07.089.", "ArticleIdList": ["10.1016/j.bcp.2011.07.089", "21820420"]}, {"Citation": "Yu X., Xu Z., Mi M., Xu H., Zhu J., Wei N., Chen K., Zhang Q., Zeng K., Wang J. Dietary taurine supplementation ameliorates diabetic retinopathy via anti-excitotoxicity of glutamate in streptozotocin-induced Sprague-Dawley rats. Neurochem. Res. 2008;33:500\u2013507. doi: 10.1007/s11064-007-9465-z.", "ArticleIdList": ["10.1007/s11064-007-9465-z", "17762918"]}, {"Citation": "Chiang S.T.-H., Yeh S.-M., Chen Y.-C., Lin S.-L., Tseng J.-K. Investigation of the protective effects of taurine against alloxan-induced diabetic retinal changes via electroretinogram and retinal histology with New Zealand white rabbits. Int. J. Endocrinol. 2014;2014:631549. doi: 10.1155/2014/631549.", "ArticleIdList": ["10.1155/2014/631549", "PMC4178915", "25298779"]}, {"Citation": "Zhu S.H., Liu B.Q., Hao M.J., Fan Y.X., Qian C., Teng P., Zhou X.W., Hu L., Liu W.T., Yuan Z.L., et al. Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-\u03baB Pathway through Upregulation of SOCS3 in Diabetic Retinopathy. Inflammation. 2017;40:1475\u20131486. doi: 10.1007/s10753-017-0571-z.", "ArticleIdList": ["10.1007/s10753-017-0571-z", "28639050"]}, {"Citation": "Kim J., Kim C.-S., Kim Y.S., Lee I.S., Kim J.S. Jakyakgamcho-tang and Its Major Component, Paeonia Lactiflora, Exhibit Potent Anti-glycation Properties. J. Exerc. Nutr. Biochem. 2016;20:60\u201364. doi: 10.20463/jenb.2016.0049.", "ArticleIdList": ["10.20463/jenb.2016.0049", "PMC5545203", "28150470"]}, {"Citation": "Mei X.-Y., Zhou L.-Y., Zhang T.-Y., Lu B., Ji L.-L. Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. Int. J. Ophthalmol. 2017;10:870\u2013877.", "ArticleIdList": ["PMC5515144", "28730076"]}, {"Citation": "Pedro R.-A., Ramon S.-A., Marc B.-B., Juan F.-B., Isabel M.-M. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17:251\u2013265. doi: 10.3109/09286586.2010.498661.", "ArticleIdList": ["10.3109/09286586.2010.498661", "20642348"]}, {"Citation": "Lee W.J., Sobrin L., Lee M.J., Kang M.H., Seong M., Cho H. The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3) Investig. Ophthalmol. Vis. Sci. 2014;55:6547\u20136553. doi: 10.1167/iovs.14-15001.", "ArticleIdList": ["10.1167/iovs.14-15001", "25205863"]}, {"Citation": "Stewart M.W. Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J. Diabetes. 2016;7:333\u2013341. doi: 10.4239/wjd.v7.i16.333.", "ArticleIdList": ["10.4239/wjd.v7.i16.333", "PMC4999649", "27625747"]}, {"Citation": "Duh E.J., Sun J.K., Stitt A.W. Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2:e93751. doi: 10.1172/jci.insight.93751.", "ArticleIdList": ["10.1172/jci.insight.93751", "PMC5518557", "28724805"]}, {"Citation": "Osaadon P., Fagan X., Lifshitz T., Levy J. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye. 2014;28:510\u2013520. doi: 10.1038/eye.2014.13.", "ArticleIdList": ["10.1038/eye.2014.13", "PMC4017101", "24525867"]}, {"Citation": "Mulki L., Foster C. Difluprednate for inflammatory eye disorders. Drugs Today (Barc.) 2011;47:327\u2013333. doi: 10.1358/dot.2011.47.5.1590791.", "ArticleIdList": ["10.1358/dot.2011.47.5.1590791", "22013563"]}, {"Citation": "Song M.-J., Kim H., Brian H., Choi K.H., Lee B.-Y. Traditional Knowledge of Wild Edible Plants on Jeju Island, Korea. NISCAIR-CSIR; New Delhi, India: 2013."}, {"Citation": "Ahmad I., Aqil F., Owais M. Modern Phytomedicine: Turning Medicinal Plants into Drugs. John Wiley & Sons; Hoboken, NJ, USA: 2006."}, {"Citation": "Dogan Y., Baslar S., Ay G., Mert H.H. The use of wild edible plants in western and central Anatolia (Turkey) Econ. Bot. 2004;58:684\u2013690. doi: 10.1663/0013-0001(2004)058[0684:TUOWEP]2.0.CO;2.", "ArticleIdList": ["10.1663/0013-0001(2004)058[0684:TUOWEP]2.0.CO;2"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "7"}, {"Year": "2018", "Month": "6", "Day": "18"}, {"Year": "2018", "Month": "6", "Day": "19"}, {"Year": "2018", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["29937497", "PMC6100391", "10.3390/molecules23071519", "molecules23071519"]}}]}